✦ LIBER ✦

Peptide therapy for diabetes

✍ Scribed by D.B. Jones; N.W. Armstrong; AlanG. Baxter; Anne Cooke

Book ID: 118554226
Publisher: The Lancet
Year: 1994
Tongue: English
Weight: 297 KB
Volume: 343
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(94)90278-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peptide therapy for diabetes in NOD mice

✍ D. Elias; I.R. Cohen 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 451 KB

Glucagon-like peptide 1 based therapy fo

Glucagon-like peptide 1 based therapy for type 2 diabetes

✍ Bao-Sheng Yu; An-Ru Wang 📂 Article 📅 2008 🏛 SP Children’s Hospital, Zhejiang University School 🌐 English ⚖ 116 KB

Peptide therapy for Type I diabetes: the

Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination

✍ I., Cohen 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 119 KB

Emerging incretin (glucagon-like peptide

Emerging incretin (glucagon-like peptide-1)-derived therapies for type 2 diabetes

✍ Alan J. Garber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

Therapy with the hsp60 peptide DiaPep277

Therapy with the hsp60 peptide DiaPep277™ in C-peptide positive type 1 diabetes patients

✍ Volkert A. L. Huurman; Katelijn Decochez; Chantal Mathieu; Irun R. Cohen; Bart O 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

## Abstract ## Background Type 1 diabetes results from a T‐cell mediated autoimmune destruction of insulin‐producing pancreatic beta‐cells. The 60‐kDa heat‐shock protein (hsp60) is one of the known target self‐antigens. An immunogenic peptide from hsp60, p277, arrested beta‐cell destruction and ma

New Therapies for Diabetes

✍ Dina E. Green 📂 Article 📅 2007 🏛 Excerpta Medica, Inc 🌐 English ⚖ 122 KB